FDA Adverse Event Malfunction Summary report: N

COAGUCHEK ® XS SYSTEM

MDR report key: 3083207 · Received April 29, 2013

Report

Report Number
1823260-2013-02627
Event Type
Malfunction
Date Received
April 29, 2013
Date of Event
March 28, 2013
Report Date
June 5, 2013
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GJS
PMA / PMN Number
K062925
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
LA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA.

Description of Event or Problem · 1

CALLER STATES PATIENT TESTED 6.0 INR ON THE COAGUCHEK XS SYSTEM WHILE A COMPARISON LAB RETURNED AS 3.9 INR. PATIENT'S COUMADIN DOSE WAS HELD FOR 48 HOURS BASED ON THE LAB RESULT. NO ADVERSE EVENT REPORTED. REQUESTED RETURN OF SUSPECT SYSTEM AND REPLACEMENT WAS SENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
183623 COAGUCHEK ® XS SYSTEM PROTHROMBIN TIME TEST STRIPS GJS ROCHE DIAGNOSTICS NA 21625211

Patients

Seq Age Sex Outcome Treatment
1 080 YR SYNTHROID DAILY| METANX DAILY| SOLU-MEDROL DAILY| NEURONTIN EVERY 8 HOURS| COUMADIN DAILY| MICRO-POTASSIUM DAILY| PROZAC DAILY| CALCITRIOL DAILY| "SELMA" 3 TIMES A DAY| COREG TWICE A DAY| AMBIEN DAILY| XANAX| DEMADEX DAILY